In this episode of MATCH B2B INSIGHTS, Benny Fluman and Brian Newman break down why so many Medtech companies with strong technology still struggle to build a predictable commercial engine. The conversation focuses on a problem many CEOs and Business Development leaders know well: pipeline that depends on conferences, referrals, and founder relationships instead of a repeatable system.The discussion explores how hospital and provider buying behavior has become more cautious, more operationally driven, and less responsive to innovation messaging alone. Benny and Brian explain why Medtech companies now need to sell not just product novelty, but adoption, workflow fit, implementation logic, and realistic ROI.Drawing on current market signals and ongoing conversations with Medtech companies in the U.S., the episode highlights the structural issues behind stalled demos, slow post-conference follow-up, CEO-dependent selling, and inconsistent deal flow. It also outlines what a repeatable commercial system actually requires, from ICP clarity and customer journey design to messaging discipline and business-outcome framing.If the patterns in this episode feel familiar, listeners are invited to contact Brian Newman for a practical diagnostic conversation about where pipeline is breaking, what process changes may be needed, and what realistic ROI expectations should look like.Email: [email protected] / WhatsApp: +972549990168